Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis

Yi-wen Shi, Jian-Gao Fan

Clin Mol Hepatol. 2023;29(Suppl):S228-S243. Published online December 14, 2022

DOI: https://doi.org/10.3350/cmh.2022.0401

View: 4315 Download: 117 Web of Science: 1 Crossref: 1

Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma

Sung Won Lee, Jonggi Choi, Seung Up Kim, Young-Suk Lim

Clin Mol Hepatol. 2021;27(3):402-412. Published online June 23, 2021

DOI: https://doi.org/10.3350/cmh.2021.0179

View: 6778 Download: 270 Web of Science: 34 Crossref: 32

Original Article

Clinical impacts of hazardous alcohol use and obesity on the outcome of entecavir therapy in treatment-naïve patients with chronic hepatitis B infection

Won Gil Chung, Hong Joo Kim, Young Gil Choe, Hyo Sun Seok, Chang Wook Chon, Yong Kyun Cho, Byung Ik Kim, Young Yool Koh

Clin Mol Hepatol. 2012;18(2):195-202. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.195

View: 9728 Download: 73 Crossref: 12

High efficacy of adefovir and entecavir combination therapy in patients with nucleoside-refractory hepatitis B

Hee Bok Chae, Mee Jin Kim, Eui Geun Seo, Yong Hyeok Choi, Hee Seung Lee, Joung Ho Han, Soon Man Yoon, Seon Mee Park, Sei Jin Youn

Clin Mol Hepatol. 2012;18(1):75-83. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.75

View: 7771 Download: 45 Crossref: 12

3

Efficacy and predictors of the virologic response to entecavir therapy in nucleoside naive patients with chronic hepatitis B

Hyung-Joon Myung, M.D., Sook-Hyang Jeong, M.D., Jin-Wook Kim, M.D., Hee-Sup Kim, M.D., Je-Hyuck Jang, M.D., Dong Ho Lee, M.D., Nayoung Kim, M.D., Jin-Hyeok Hwang, M.D., Young Soo Park, M.D., Sang-Hyub Lee, M.D.

Clin Mol Hepatol. 2010;16(1):57-65. Published online March 26, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.1.57

View: 5716 Download: 36 Crossref: 9

Efficacy of initial treatment with peginterferon alpha-2a versus peginterferon alpha-2b in combination with ribavirin in naive chronic hepatitis C patients Living in Daejeon and Chungcheong Province in Korea: A comparative study

Jeong Il Kim, M.D, Seok Hyun Kim, M.D., Byung Seok Lee, M.D., Heon Young Lee, M.D., Tae Hee Lee, M.D. Young Woo Kang, M.D. Hyang Ie Lee, M.D. An Na Kim, M.D. Soon Woo Nam, M.D. Byeong Chool Park, M.D. Hee Bok Chae, M.D. Seok Bae Kim, M.D. Il Han Song, M.D. Ji Young Park, M.D. Hong Su Kim, M.D.

Clin Mol Hepatol. 2008;14(4):493-502. Published online December 31, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.4.493

View: 4732 Download: 21 Crossref: 9

Correspondence

Correspondence to editorials on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”

Woo Hyun Paik, Do Hyun Park

Received November 4, 2024 Accepted November 7, 2024

DOI: https://doi.org/10.3350/cmh.2024.0989 [Accepted]

View: 166 Download: 13

1 |

Viewed By 5095	MAFLD: How is it different from NAFLD?
Viewed By 5072	Examining the therapeutic landscape of beta-blockers in portal hypertension
Viewed By 4496	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4471	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4363	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Cited By 248	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 198	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 145	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 138	MAFLD: How is it different from NAFLD?
Cited By 113	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search